Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by Rabin Medical Center.
Recruitment status was  Recruiting
Information provided by:
Rabin Medical Center Identifier:
First received: August 17, 2008
Last updated: March 25, 2010
Last verified: December 2008
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)